News | March 28, 2022
Tata Capital Healthcare Fund II raises Rs 955 crore
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
A staggering 65% of the TB cases in India are in the 15-45 age group
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
The company has has 10 existing labs in India
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
Subscribe To Our Newsletter & Stay Updated
